UBE2V2P4

Across TCGA pan-cancer cohorts, UBE2V2P4 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated UBE2V2P4 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher UBE2V2P4 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated UBE2V2P4 expression acts as an unfavorable survival marker, although some lineages such as LUSC and BRCA show a favorable association.

LUSC, SKCM, and BRCA are the cancer types where UBE2V2P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.740	0.386	.002	27	view →
SKCM	OS	Tertile	II,III,IV	0.180	0.379	.001	24	view →
BRCA	OS	Tertile	III,IV	0.937	0.804	.011	18	view →
CHOL	DFS	Tertile	All	0.037	0.497	.004	9	view →
ACC	DFS	Tertile	IV	0.068	0.402	.031	9	view →
LAML	DFS	Quartile	All	0.512	0.273	.037	4	view →
OV	OS	Quartile	IV	0.562	0.896	.030	4	view →
STAD	OS	Quartile	All	0.643	0.442	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

UBE2V2P4–LUSC (DFS)

Open the LUSC breakdown →